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ABSTRACT 
Creatine and trimethylamine oxide (TMAO) are the chief nitrogenous constituents 
of normal Lophius urine, and both of these organic bases characteristically have high 
urine/plasma concentration  ratios. 
Competition  studies  involving various  organic  bases  indicate  that creatine  and 
TMAO are excreted independently  by separate  transport mechanisms. 
TMAO excretion  is inhibited  competitively  by tetraethylammonium ion  (TEA) 
and by cyanine  dye No.  863--compounds  previously  shown to be  transferred  ac- 
tively by an organic base-secreting mechanism of general occurrence among verte- 
brates. 
TEA does not inhibit competitively  the active  tubular reabsorpfion  of TMAO 
in Squalus with doses which markedly depress its tubular excretion in Lophius. Glycine, 
which inhibits creatine reabsorption in the dog, does not interfere competitively with 
its  secretion  in  Lophius. 
The ability of various vertebrate  renal  tubules to  transport actively such 
organic bases as Nrmethyinicotinamide (1, 2), tetraethylammonium ion (3-5), 
and cyanine dyes (6,  7) against concentration gradients has recently received 
considerable  attention.  The  transfer mechanism seems  to  be  of general  oc- 
currence among vertebrates, having its counterpart in another tubular process 
which involves the tubular excretion of such organic acids as the phenolsulfon- 
phthaleins,  p-aminohippuric acid,  and  the penicillins (for review, see  Smith 
8)).  Transport  of both  acids  and bases  is  energy-dependent and  subject  to 
competitive inhibition. 
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The renal tubules of Lophius consist exclusively of brush border cells;  this 
lack  of regional  differentiation,  together  with  the  absence  of glomeruli  (9), 
makes the Lophius kidney especially suitable for the study of active secretory 
processes.  Grollrnan  (10)  analyzed  the  nitrogenous  constituents  of Lophius 
urine and was the first to point out that trimethylamine oxide (TMAO) con- 
stitutes a  large fraction of the total non-protein nitrogen  (NPN). TMAO fre- 
quently contributes more than 50 per cent of the total urinary NPN, and to- 
gether with creatine comprises 80 to 90 per cent of NPN in urine.  Brull and 
Nizet (11)  have recently confirmed the observation that TMAO and creatine 
are the chief NPN constituents of Lophius urine. 
The  object  of  the  present  study  is  to  attempt  a  characterization  of  the 
transfer  mechanism  involved  in  the  secretion  of  these  naturally  occurring 
organic bases. 
Methods 
The experimental procedures for handling  the fish were described  in earlier papers 
(12-14).  Creatine was analyzed in 5:1 tungstic acid filtrates of plasma and in 100:1 
dilutions  of urine by the method of Taussky (15), and creatinine in the same sam- 
ples was determined by the alkaline  picrate method of Folin  and Wu  (16).  Inulin 
was analyzed by the  resorcinol  method as described  by Schreiner  (17).  TMAO in 
plasma filtrates and in urine  was reduced  to trimethylamine with metallic zinc or 
titanous  chloride  in acid  medium,  and  formaldehyde was added  to hold  back the 
ammonia. After 40 per cent KOH had been added to the outer chamber of a Conway 
diffusion unit (18), the liberated amine was allowed  to diffuse  into  the  center well 
where it was trapped in a 0.5 per cent boric acid buffer solution  containing  indicator, 
and determined subsequently by back-titration with 0.005 N HCI. This basic volatile 
non-ammonia component was previously identified  as trimethylamine by Grollman 
(10) who showed that all the NPN in urine, not identifiable  as ammonia, urea, amino 
acid,  creatine,  or creatinine was accounted  for as TMAO.  Recoveries of standard 
TMAO from urine samples were complete,  but determinations in plasma were com- 
plicated by very low normal levels and by the presence  of some unidentifiable  inter- 
fering factor. 
The method  described  by Mitchell  and  Clark  (19),  modified  by Rennick  el at. 
(3),  was used for the analysis of tetraethylammonium ion  (TEA). 
RESULTS 
The concentrations  of creatine  and TMAO were high in urine  taken from 
Lophii immediately after capture. As shown in Table I, the urinary concentra- 
tions of both compounds, and their rates of excretion decreased progressively 
during  captivity,  suggesting  an  exogenous  source  of  TMAO  and  creatine. 
Creatine urine/plasma concentration ratios frequently were as high as 100:1. 
TMAO could not be accurately determined in plasma; however, plasma levels 
were probably well below 1 #M per ml. suggesting that U/P ratios were of the 
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Creatine was injected into three Lopkii after two or three control periods to 
test  for  possible  transfer  competition between creatine and  TMAO.  Owing 
to the extremely low solubility of creatine, its plasma level could not be raised 
much above 1/~  per ml., but even at this relatively low plasma level creatine 
TABLE I 
A  Control Experiment,  Illustrating  the Characteristic Spontaneous Decline Noted in  Urinary 
Trimethflamine  Oxide (TMAO) and Creatine Concentrations under Laboratory Conditions 
Lopkius 62, 8.2 kg. 
Sample 
Urine 1 .... 
Urine 2 .... 
Urine 3 .... 
Urine 4 .... 
Urine 5 .... 
Urine 6 .... 
Time 
~/If$. 
O-7.7 
7.7-15.7 
15.7-21.8 
21.8-29.8 
29.8-38.8 
38.8-45.6 
Urine flow 
ml.lk~.l~ay 
24.6 
16.3 
21.2 
21.4 
25.7 
26.2 
TMAO 
vat/ml.  ~t/kg./da~ 
24.8  610 
12.6  206 
5.6  119 
5.0  107 
3.0  77 
3.0  79 
Creat~e 
~tt/ml.  i~la/kg./day 
40.1  985 
16.6  270 
18.3  388 
17.2  368 
9.7  250 
9.0  236 
TABLE II 
Independence  of Creatine and  TMAO  Secretory Mechanisms  Disclosed by  the Inability  of 
Intramuscularly  Administered  Creatine to Inkibit  Competiti~dy  tke Excretion  of TMAO. 
Excretory Rates  of Creatine were Markedly  Elevated by Its Inject,  ion without Affecting  the 
Characteristic Spontaneous Decline in TMAO  Urine Concentration or Excretory Rate Noted 
under Control Conditions 
Lopkius 89, 2.8 kg. 
Sample  Time  Urine  flow  TMAO  Crestine 
Plasma 1  ....... 
Urine 1 ......... 
Urine 2 ......... 
Plasma 2 ........ 
Urine 3 ......... 
Urine 4 ......... 
Plasma 3 ........ 
IllS. 
0 
0-3.5 
3.5-6.5 
6.5 
6.5 
6.5-9.7 
9.7-11.5 
11.5 
ml.lkg.lday 
22.7 
24.3 
~/mL  ~/k&./day 
6.6 
30 ml. of 1.3 per cent creatine intramuscularly 
28.5  5.1  144  51.1  1450 
28.0  4.7  130  53.5  1500 
1.02 
tat/ml,  ta~lk~./iay 
0.17 
17.2  390 
14.0  340 
0.14 
excretion increased significantly, and its U/P  concentration ratios were  de- 
pressed. No effect of elevated creatine plasma levels on TMAO excretion was 
demonstrated. Table II records  the  observations made on one of these fish. 
Elevation of creatlnlne plasma levels had no effect on the excretion of either 
creatine or TMAO as disclosed by observations made on six Lophii.  One of 
these experiments is summarized in Table HI.  It is interesting to note that 
creatinine is probably not excreted as efficiently as is creatine. Normally creati- 322  SECRETION  Ol  ~ ORGANIC  BASES 
nine plasma levels are too low to measure, but when they are elevated to levels 
comparable to those of creatine, U/P ratios of creatinine are only one-tenth 
those of creatine (compare Tables II and III). 
TABLE III 
Independence  of the Creatinine Secretory Mechanism  Disclosed by the Inability of Intramuscu- 
larly Administered  Creatinin¢  to Inhibit  Compegtivdy  the Excretion  of Either  TMAO  or 
Creatinc. Exogenous  Creatinine,  While Activdy Excreted Itself,  in High Plasma Concentra- 
tions Does Not Affect the Urinary Concentrations or Excretory Rates of TMAO and Creatine 
Lophius 100, 9.1 kg. 
Sample 
Plasma 1 ..... 
Urine 1 ...... 
Urine 2 ...... 
Urine 3 ...... 
Urine 4 ...... 
Urine 5 ...... 
Urine 6 ...... 
Plasma 2 ..... 
Time 
]itS. 
0 
0-4.4 
4.4-7.4 
7.4 
7.4-10.2 
10.2-14.4 
14.4-18.4 
18.4-22.8 
22.8 
U~ne flow  TMAO 
21.6  ]  26.0  561 
19.4  /  22.2  431 
Creatine 
t,~/mt.  ~,st/kg./  day 
0.4 
19.7  425 
14.5  282 
Creatlnine 
~u/ml. 
20  ml.  of 8 per  cent creatinine  intramuscularly 
20.8  14.5  302  10.4  216  9.5 
20.7  15.0  311  9.9  205  8.3 
19.0  13.3  252  7.5  143  6.2 
19.6  14.3  280  6.1  120  5.8 
1.8 
day 
m 
m 
198 
171 
118 
113 
TABLE IV 
Competitive  Transport  Inhibition  of  Endogenous  TMAO  by  Injected  TEA,  with  Creatine 
Transfer  Unaffected by TEA Administration 
Lophius 107, 4.5 kg. 
Sample  ii  Time 
krs. 
Urine I.  0-3.4 
Urine 2.  3.4--6.7 
6.7 
Urine 3...  6.7-9.1 
Urine 4.  9.1-13.7 
Urine 5.  13.7-17.4 
Urine 6.  17.4--20.0 
Urine flow  TMAO  Creatine 
ml.lkg.I  ~ulkg.l  t,•lml.  ~,ulkg.I  ~1 rig.  day  ] t~/ml,  day  day 
I 
20.3  [  20.0  406  36.5  742  -- 
22.0  [  14.5  319  30.9  680 
3 ml. of 1 per cent TEA-Br intramuscularly 
20.2  4.0  81  25.3  511  2.43 
18.3  1.8  32  19.3  354  1.97 
18.9  3.3  62  15.0  284  1.18 
18.6  2.8  51  10.0  188  0.75 
TEA 
day 
49.0 
36.1 
22.3 
14.0 
Tetraethylammonium ion  (TEA)  was  itself  efficiently  excreted  by  the 
aglomerular kidney.  High  concentrations occurred  in  the  urine,  even when 
pl~ma  levels were  too  low  to  permit quantitative evaluation. In a  typical 
experiment (Table IV) the recovery of administered TEA-Br was 35.1 per cent 
in '15.3 hours with 9.5,  13.7,  6.7,  and 5.2 per cent excreted during collection 
periods 3, 4, 5, and 6 respectively. Tea-Br, when given intramuscularly, very R.  P.  FORSTER,  :F.  BERGLUND~ AND  B.  R.  RENNICK  323 
markedly depressed  the  excretion of TMAO,  without significantly affecting 
urine flow or creatine excretion. The same dose administered intravenously 
almost completely supressed TMAO excretion. 
To  determine  whether  TEA  inhibits  the  active  tubular  reabsorption  of 
TMAO in elasmobranchs as it does the excretion of TMAO in Lophius, doses 
comparable to those injected into Lophius were administered to the dogfish 
(Squalus acanthias). Table V summarizes an experiment in which it was dem- 
onstrated that TMAO in Squatus is reabsorbed as efficiently as is urea, with 
more than 95 per cent of the filtered load being reabsorbed. The simultaneous 
presence of TEA did not affect either of these reabsorptive processes even when 
TABLE V 
Lack  of Transfer Competition Involving the Active Reabsorption of TMAO in Squalus  and 
the  Tubular Excretion  of Exogenous TEA.  Urea Reabsorption is Likewise Unaffected by 
TEA Administragon 
Dogfish 30, 1.9 kg. 
Time 
hrs. 
0-2.2 
2.2-4.5 
4.5-7.4 
7.4 
7.4-10.0 
10.0 
10.0-12.7 
12.7-15.2 
Urine flow  GFR* 
day  day 
30.5  79.4 
25.0  63.0 
17.2  53.1 
2ml.  of 
17.9  [  46.0 
2  ml.  of 
16.8  48.7 
31.4  52.8 
TMAO 
Plasma  Urine  Filtered Excreted  Rre~  i 
/'"/"  I  I  [ 
89,21n.II  7.05 I0. 195.2 
87.6112.7  5.47 10.32194.2 
85.7  [  8.2  4.65  0.15  96.8 
TEA-Br  (8  mg./ml.)  intramuscularly 
1 711061  388  I  0.19  195.2 
TEA-Br  (8  mg./ml.)  intramuscularly 
181"916"71  3.96  0"11197"2 
80.1  2.2  4.23  0.07  98.3 
~rea re 
bsorbe 
95.0 
94.5 
96.2 
95.0 
95.0 
97.8 
TEA 
~/ml. 
2.5 
2.5 
0.9 
* Glomerular filtration rate. 
repeated injections resulted in urinary concentrations higher than those which 
occurred when TMAO secretion in Lophius was significantly depressed. TEA 
was secreted as actively by Squalus as by Lophius. Urinary TEA concentrations 
in both species as high as 2.5 p~ per ml.  (32.5 rag. per cent) occurred when 
simultaneous plasma concentrations were  too low to  estimate. 
Cyanine dye No. 863, which previously had been shown in birds and mam- 
mals to inhibit competitively the renal tubular transport of other members of 
the organic base series  (6, 7), depressed effectively the excretion of TMAO in 
experiments on four Lophii. Table VI summarizes an experiment in which 0.5 
rag. of the dye injected intramuscularly after two control periods effectively 
depressed  the  excretion of TMAO  without affecting urine flow or  creatine 
excretion. The cyanine dye itself was visibly excreted,  imparting a  distinct 
yellow color to the otherwise colorless Lophius urine. 324  S]~CILETION  O:P  ORGANIC  BASES 
Probenecid  • (benemid),  which  inhibits the  tubular excretion  of  penicillin, 
PAH, and other organic acids (20) as well as the tubular excretion of urea in the 
frog (21)  and the tubular reabsorption of uric acid in certain mammals (20), 
TABLE VI 
Competitive InMbition Involving TMAO and Cyanine Dye No. 863. The Tubular Excretion 
of Creatine is Unaffected by Injection of the Basic Dye 
Lophius 99, 1.5 kg. 
Sample 
Urine 1 ....... 
Urine 2 ........ 
Plasma ......... 
Urine 3 ........ 
Urine 4 ........ 
Urine 5 ........ 
Urine 6 ........ 
Time 
Jtr$. 
0-3.6 
3.6-8.0 
8.0 
8.0 
8.0-12.2 
12.2-16.7 
16.7-21.3 
21.3-25.3 
Urine flow  TMAO 
ml.lkg.lday i  ~/ml.  ~lkg.lday 
35.4  I  11.5  ~ 
36.2  10.8 
Creatine 
~u/mt.  t~u/kg.I 
day 
5.3  188 
3.7  134 
0.17 
t ml. of cyaulneNo. 863(0.Smg./ml.)intramuscularly 
30.7  5.3  161  4.4  135 
46.2  3.8  173  4.3  199 
33.5  3.8  126  3.4  114 
45.1  2.8  124  2.8  126 
TABLE VII 
Independence of the Base-Secreting Mechanism (TMAO and Creatine) and the Organic Acid 
Transfer System (PAH)  as Disclosed by the Inhibitory Effect of Probenecid on PAH 
Excretion, and Not on TMAO or Creatine Excretion 
Lophius 64, 10.0 kg. 
Sample 
Urine 1.. 
Urine 2.. 
Plasma 1. 
Urine 3.. 
Urine 4.. 
Plasma 2. 
Time 
hrs. 
0 
...  0-5.8 
•.,  6.8-14.9 
•..  14.9 
14.9 
•..  14.9-23.9 
...  23.9-29.7 
...  29.7 
Llrineflo_  w  TMAO  Creatine  PAl{ 
~,~lkg.I  ~,~/ml.  ~lkg.I  I, ul~l.  ~,ul~f.I  ,  ral  .I  ../  ml.  day  day 
20 ml. of 20 per cent PAH intramuscularly 
15.5  35.2  546  17.8  276  [ 315  4880 
16.8  22.6  380  10.7  180  I 254  4260 
0.12  44 
1 per cent probenecid: 30 ml. intravenously and 30 ml. 
intramuscularly 
18.2  17.4  317  8.7  158  100  1815 
17.1  22.8  383  7.8  133  101  1720 
O. 16  43 
did not affect the excretion of creatine and TMAO in Lophius with doses that 
did simultaneously depress the secretion of PAH by more than 50 per cent. A 
typical experiment is shown in Table VII. 
Glycine has been shown to depress the reabsorption of creatine in the renal 
tubules of the dog (22). When glycine was given to three Lophii, in doses rang- 
ing from 0.7 to 3.0 gm./kg, body weight intravenously and intramuscularly, it R. P. FORSTER,  ~. BERGLUND,  AND  B. R. RENNICK  325 
did not depress the excretion of creatine. With the higher doses, glycine defi- 
nitely increased  creatine excretion by elevating the plasma level of creatine. 
Phlorizin has been shown to depress the tubular excretion of creatine in the 
teleost E~nepludus morio (23), but an intravenous dose as high as 680 mg./kg, 
body weight in one Lophius failed to depress creatine excretion. 
DISCUSSION 
The advantages provided by the aglomerular renal tubules of Lopbius  for the 
study of discrete secretory processes are offset, to some extent,  by the dif- 
ficulty encountered in maintaining adequate control conditions. The fish do not 
feed in the laboratory, and they seem incapable of digesting what food is in the 
stomach at  the  time of capture.  Hence,  the effects of various experimental 
factors on the transport rates of such compounds as TMAO and creatine which 
presumably originate in the diet must be interpreted against a background of 
spontaneous declines in the plasma concentrations of these substances. Further- 
more, Lophius and other marine teleosts exhibit a  characteristic  "laboratory 
diuresis"  accompanied  by progressive  hemodilution  (24)  which  also  makes 
maintenance of standard control conditions difficult. 
Evidence against the existence of a single mechanism involved in the trans- 
port of naturally occurring organic bases by the aglomerular tubule was pro- 
vided by the observation that creatine in elevated plasma concentrations did 
not alter  transfer rates of TMAO,  the other important  basic constituent in 
Lophius plasma. The reciprocal experiment, testing for competitive inhibition 
of creatine excretion by elevating the TMAO plasma levels, was precluded by 
the unavailability of sufficiently large amounts of the oxide to raise its plasma 
concentration significantly.  Both the creatine and the TMAO transfer systems 
appear to operate against an electrochemical gradient, and can be thought of as 
"active"  processes.  Creatinine  is  not  an  important  constituent  of Lophius 
plasma.  It  appears  to  be transported  by a  third  base-secreting mechanism 
because elevation of its plasma concentrations  did not result in  competitive 
inhibition  of the transfer of either TMAO or creatine. 
Further evidence for the mutual independence of the TMAO and the creatine 
transfer mechanisms was provided by the observation that TEA, itself actively 
excreted, inhibited the transport of TMAO markedly without affecting creatine 
secretion. Cyanine dye No. 863 similarly inhibited transfer of TMAO but not 
creatine, indicating that the base-secreting mechanism in Lophius  which trans- 
ports TMAO is probably identical with the generally occurring system previ- 
ously demonstrated in other vertebrate nephrons which competitively transfers 
TEA, Nl-methylnicotinamide, basic cyanine dyes, and certain other quaternary 
bases. 
A  fundamental  difference  between the  secretion and  the  reabsorption  of 
identical  compounds was again  disclosed by the observation that  TEA  de- 326  SECRETION O1  ~  ORGANIC BASES 
pressed TMAO  secretion  in Lophius  but did not affect its  reabsorption  in 
Squegus. Other examples of the contrasting characteristics of these oppositely 
oriented transfer processes have previously been demonstrated. Probenecid has 
been shown to block urea secretion in the frog (21)  but not its active reab- 
sorption  in  Squa/us  (13).  Carinamide inhibits  the  secretion  of sulfate  and 
thiosulfate in Lophius (14) and of thiosulfate in man (25) and in dog (26), but 
does not affect the reabsorption of sulfate (14) or of thiosulfate (14, 25, 26) in 
the dog. Glycine inhibits the reabsorption of creatine (22) and sulfate in the dog 
(27),  but does not affect the secretion of sulfate (14) and creatine in Lophius. 
The glycine results suggest that the competitor must be actively transported 
itself in order to act effectively as an inhibitor, and the TEA observations 
indicate further that the competitor must be transported in the same direction 
as the inhibited substance. An exception appears to be the inhibitory effect of 
probenecid on both uric acid secretion in the rabbit (28) and on its reabsorption 
in man and other mammals (20).  How probenecid itself is handled by renal 
tubules while it exerts  these inhibitory effects has not been clearly demon- 
strated. These observations on various vertebrates clearly cannot support the 
hypothesis that identical intracel}ular mechanisms are involved in the active 
transfer of a  specific substance when in one species the compound is secreted 
and in another it is actively reabsorbed. 
We are grateful for the helpful cooperation of Dr. Richard  L. Malvin,  and for the 
technical assistance of John C. Bernhardt, Jr., Peggy Forster,  Robert B. Howe, and 
Susan Michelson. Captain Perry Lawson and the crew of his trawler generously pro- 
vided facilities  for  collecting  the  Lophii  used  in  these  experiments. 
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